Mehmet Can Girgin

Mehmet Can Girgin

Auto-generated profile, based on publicly available information

Mehmet Can Girgin

Beykent University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2026 in The Egyptian Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
Asli Bahar UcarAsli Bahar Ucar
Asli Bahar Ucar
MUMehmet Unaldi
Mehmet Unaldi
NKNeslihan Kaytuoglu
Neslihan Kaytuoglu
BEBusra Erdem
Busra Erdem
BOBilgen Ozkaya
Bilgen Ozkaya
OKOzgur Karcioglu
Ozgur Karcioglu
Pain in older adults is highly prevalent and persistently undertreated, and its management becomes substantially more hazardous when renal, hepatic, or respiratory failure co-exists. Age-related pharmacokinetic changes — reduced hepatic blood flow and cytochrome P450 activity, declining glomerular filtration, and altered body composition — are compounded by pharmacodynamic changes, including heightened central nervous system sensitivity and reduced homeostatic reserve. This narrative review synthesises contemporary evidence and current prescribing frameworks into an organ-failure-stratified approach to analgesic selection. Paracetamol and topical agents remain the safest first-line options across all three organ failure states. Non-steroidal anti-inflammatory drugs should be avoided when the estimated glomerular filtration rate falls below 30 mL/min and are contraindicated in cirrhosis. Opioids remain indispensable for moderate-to-severe pain but require dose reduction, interval extension, and close monitoring: fentanyl and buprenorphine are preferred in renal failure, whereas morphine, codeine, and meperidine should be avoided; all opioid doses must be reduced in hepatic failure; and in respiratory failure or chronic obstructive pulmonary disease opioids should be given at the lowest effective dose and never combined with other central nervous system depressants. Adjuvant analgesics carry agent-specific organ restrictions. Frailty, cognitive impairment, and polypharmacy further modify risk. ‘Start low, go slow’ must be calibrated individually to the type and severity of organ dysfunction present.

21 August 2026 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
CACanan Akman
Canan Akman
Asli Bahar UcarAsli Bahar Ucar
Asli Bahar Ucar
MGMehmet Can Girgin
Mehmet Can Girgin
BEBusra Erdem
Busra Erdem
GYGokhan Yilmaz
Gokhan Yilmaz
OKOzgur Karcioglu
Ozgur Karcioglu

10 November 2026 in Bratislava Medical Journal
Verified
Journal Article
Closed access
PDF file
CACanan Akman
Canan Akman
BGBehnan Gulunay
Behnan Gulunay
SBSezin Bozkurt
Sezin Bozkurt
ASALİ SAĞLIK
ALİ SAĞLIK
MGMehmet Can Girgin
Mehmet Can Girgin
OKOzgur Karcioglu
Ozgur Karcioglu

17 October 2026 in Bratislava Medical Journal
Verified
Journal Article
Closed access
PDF file
FGFatma Mutlu Kukul Güven
Fatma Mutlu Kukul Güven
SSSennaz Sahin
Sennaz Sahin
NKNeslihan Kaytuoglu
Neslihan Kaytuoglu
PVPinar Vargun
Pinar Vargun
MGMehmet Can Girgin
Mehmet Can Girgin
OKOzgur Karcioglu
Ozgur Karcioglu